Research

We encourage our patients to consider taking part in research studies where appropriate. Only through such research can we hope to determine which treatments are best and therefore improve the outcomes for future patients.

You can also support our research by making a donation to our Upper GI Research Fund (Surgical Research – Q7114), which is part of the Nottingham University Hospitals Charity (charity number 1059049).

• Oesophageal cancer clinical and molecular stratification (OCCAMS) incorporating international cancer genome consortium
• Radiotherapy after oesophageal cancer stenting (ROCS)
• Neo-AEGIS: A randomised clinical trial of neoadjuvant and adjuvant chemotherapy (modified MAGIC regimen) versus neoadjuvant chemoradiation (CROSS protocol) in adenocarcinoma of the oesophagus and oesophago-gastric junction
• A feasibility study of adjuvant STATin therapy in the prevention of postoperative recurrence of oesophageal adenocarcinoma (the STATROC feasibility study)
• Add-aspirin trial: A phase III double-blind placebo-controlled randomised trial assessing the addition of aspirin after standard primary therapy in early stage common solid tumours
• PREoperative intraVENous iron to treat anaemia in major surgery (PREVENTT)

• A randomised controlled trial comparing the clinical effectiveness and cost-effectiveness of laparoscopic cholecystectomy compared with observation/conservative management for preventing recurrent symptoms and complications in adults with uncomplicated symptomatic gallstones (C-Gall)
• Hughes abdominal repair trial – abdominal wall closure techniques to reduce incidence of incisional hernias (HART)